You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

PEG-rhG-CSF

Showing 26 - 50 of 2,545
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Elderly Lymphoma Patients Trial in Guangzhou (PEG-rhG-CSF)

Unknown status
  • Elderly Lymphoma Patients
  • PEG-rhG-CSF
  • Guangzhou, China
    Sun Yat-sen University Cancer Hospital
Mar 12, 2019

Acute Myeloid Leukemia, MDS, Myeloid Malignancies Trial in Boston (Decitabine, Filgrastim)

Not yet recruiting
  • Acute Myeloid Leukemia
  • +6 more
  • Boston, Massachusetts
  • +1 more
Mar 31, 2023

Clinical Application of PEG-rhG-CSF During Chemotherapy in Solid

Unknown status
  • Neutropenia
  • Nanchong, Sichuan, China
    Affiliated Hospital of North Sichuan Medical College
Jan 8, 2019

Acute Myeloid Leukemia Trial in Seattle (drug, biological, other)

Active, not recruiting
Has Results
  • Acute Myeloid Leukemia
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Oct 10, 2022

Small Cell Lung Cancer, PEG-rhG-CSF Trial in Beijing (PEG-rhG-CSF)

Unknown status
  • Small Cell Lung Cancer
  • PEG-rhG-CSF
  • PEG-rhG-CSF
  • Beijing, Beijing, China
    Bejing Cancer Hospital
Dec 16, 2018

PEG-rhG-CSF in Medium-high Risk of FN in Chemotherapy of Breast

Unknown status
  • Febrile Neutropenia
  • PEGCSF first level prophylactic use
  • PEGCSF second level prophylactic use
  • (no location specified)
Dec 26, 2018

Retinoblastoma Trial in Memphis (drug, other, procedure, radiation)

Recruiting
  • Retinoblastoma
  • Memphis, Tennessee
    St. Jude Children's Research Hospital
Aug 25, 2022

Cost-effectiveness of PEG-rhG-CSF for Primary vs Secondary

Unknown status
  • Chemotherapy-induced Neutropenia
  • PEG-rhG-CSF
  • Hefei, Anhui, China
    Anhui Provincial cancer center
Oct 9, 2018

Neutropenia Trial in Beijing (Pegfilgrastim)

Completed
  • Neutropenia
  • Beijing, Beijing, China
    Department of Medical Oncology
Mar 12, 2022

Leukemia Trial in Houston (Cyclophosphamide, Vincristine, Blinatumomab)

Not yet recruiting
  • Leukemia
  • Houston, Texas
    M D Anderson Cancer Center
Dec 23, 2022

Brain Tumor, Brain Tumor, Recurrent, Brain Tumor, Refractory Trial in Memphis (Prexasertib, Cyclophosphamide, Gemcitabine)

Active, not recruiting
  • Brain Tumor
  • +12 more
  • Memphis, Tennessee
    St. Jude Children's Research Hospital
Oct 20, 2022

Acute Biphenotypic Leukemia, Acute Myeloid Leukemia, Mixed Phenotype Acute Leukemia Trial in Seattle (Cladribine, Cytarabine,

Recruiting
  • Acute Biphenotypic Leukemia
  • +11 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Oct 18, 2022

Acute Lymphoblastic Leukemia in Remission, Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome, Acute Myeloid

Recruiting
  • Acute Lymphoblastic Leukemia in Remission
  • +11 more
  • Astatine At 211 Anti-CD45 Monoclonal Antibody BC8-B10
  • +8 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Oct 24, 2022

Non Small Cell Lung Cancer, Breast Cancer Trial in China (YPEG-rhG-CSF, 20µg/kg, single s.c. at 48hrs after chemo for each

Completed
  • Non Small Cell Lung Cancer
  • Breast Cancer
  • YPEG-rhG-CSF, 20μg/kg, single s.c. at 48hrs after chemotherapy for each experimental cycle
  • +3 more
  • Zhangzhou, Fujian, China
  • +11 more
Jul 15, 2018

Recurrent Hodgkin Lymphoma, Refractory Hodgkin Lymphoma Trial in Duarte (Basiliximab, Carmustine, Cytarabine)

Recruiting
  • Recurrent Hodgkin Lymphoma
  • Refractory Hodgkin Lymphoma
  • Basiliximab
  • +6 more
  • Duarte, California
    City of Hope Medical Center
Jun 16, 2022

Healthy Volunteers Trial in Cypress (PEG-rhG-CSF, Neulasta (PEG-rhG-CSF))

Completed
  • Healthy Volunteers
  • PEG-rhG-CSF
  • Neulasta (PEG-rhG-CSF)
  • Cypress, California
    WCCT Global Inc.
Jul 2, 2018

Childhood Solid Tumors Trial in Memphis (Talazoparib, Irinotecan, Temozolomide)

Completed
  • Childhood Solid Tumors
  • Memphis, Tennessee
    St. Jude Children's Research Hospital
Feb 8, 2021

Metastatic Breast Cancer Trial in Guangzhou, Shantou (Mecapegfilgrastim, dalpiciclib, exemestane, fulvestrant, letrozole,

Not yet recruiting
  • Metastatic Breast Cancer
  • Guangzhou, Guangdong, China
  • +2 more
Jul 17, 2022

Early-stage Breast Cancer Trial in Ottawa (Granulocyte Colony-Stimulating Factor (G-CSF), Omission of Granulocyte

Not yet recruiting
  • Early-stage Breast Cancer
  • Granulocyte Colony-Stimulating Factor (G-CSF)
  • Omission of Granulocyte Colony-Stimulating Factor (G-CSF)
  • Ottawa, Ontario, Canada
    The Ottawa Hospital Cancer Centre
Feb 22, 2023

Leukemia, Acute Lymphoblastic Leukemia Trial in Houston (Rituximab, Cyclophosphamide (CTX), Doxorubicin)

Completed
Has Results
  • Leukemia
  • Acute Lymphoblastic Leukemia
  • Houston, Texas
    UT MD Anderson Cancer Center
Dec 1, 2020

Breast Cancer, Neutropenia, Febrile Neutropenia Trial in Seoul (Filgrastim, Peg-filgrastim)

Terminated
  • Breast Cancer
  • +2 more
  • Seoul, Korea, Republic of
    Asan Medical Center
Jul 29, 2020

Hodgkin's Lymphoma Trial in Houston (Panobinostat, Ifosfamide, Mesna)

Completed
Has Results
  • Hodgkin's Lymphoma
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Dec 10, 2020

Drug/Agent Toxicity by Tissue/Organ, Leukemia Trial in Canada, Puerto Rico, United States (asparaginase, cyclophosphamide,

Completed
Has Results
  • Drug/Agent Toxicity by Tissue/Organ
  • Leukemia
  • Boston, Massachusetts
  • +9 more
Nov 9, 2022

Acute Lymphoblastic Leukemia Trial in Memphis (Prednisone, Vincristine, Daunorubicin, PEG-L-asparaginase, Erwinia

Completed
Has Results
  • Acute Lymphoblastic Leukemia
  • Prednisone, Vincristine, Daunorubicin, PEG-L-asparaginase, Erwinia L-asparaginase, Doxorubicin, Cyclophosphamide, Cytarabine, Thioguanine
  • Clofarabine, Methotrexate, Mercaptopurine, Dexamethasone, Etoposide, Dasatinib
  • Memphis, Tennessee
    St. Jude Children's Research Hospital
Jul 26, 2022

Hepatitis B, Chronic Trial in Beijing (Granulocyte Macrophage-colony Stimulating Factor, Entecavir)

Terminated
  • Hepatitis B, Chronic
  • Granulocyte Macrophage-colony Stimulating Factor
  • Entecavir
  • Beijing, Beijing, China
    302 Military Hospital
Mar 9, 2022